10.77 USD
↘ 0.18 (1.64%)AT CLOSE (03:59 PM EDT)
MoonLake Immunotherapeutics Class A Ordinary Shares
MLTXNASDAQ • USD
11.08
↗ 0.31 (2.89%)
POST MARKET (AS OF 04:50 PM EDT)
Post Market
AS OF 04:50 PM EDT
11.08
↗ 0.31 (2.89%)
Market: OPEN
MLTX is currently priced at $11.08. Technical and fundamental signals converge bearish — technicals rate "Sell" while fundamentals read "Sell". Notable factors include a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.
Technical & fundamental data as of Oct 6, 2026.
Open?$10.81
High?$11.29
Low?$10.71
Prev. Close?$10.95
Volume?1.4M
Avg. Volume?1.6M
VWAP?$10.97
Rel. Volume?0.85x
Bid / Ask
Bid?$9.25 × 100
Ask?$12.90 × 100
Spread?$3.65
Midpoint?$11.08
Valuation & Ratios
Market Cap?931.9M
Shares Out?85.1M
Float?61.4M
Float %?83.4%
P/E Ratio?N/A
P/B Ratio?2.18
EPS?-$3.08
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients. It is currently developing SLK in inflammatory diseases in dermatology and rheumatology where the pathophysiology is known to be driven by IL-17A and IL-17F.
Employees
130
Market Cap
931.9M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2022-04-06
Address
DORFSTRASSE 29
ZUG, V8 6300
Phone: 41 41 510 8022
ZUG, V8 6300
Phone: 41 41 510 8022
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?33
Momentum?50
Short Sent.?44
Piotroski F-Score?0/9Weak
Altman Z-Score?1.94Grey
Confidence?60%Moderate
Short InterestHigh
Short % of Float?14.57%High
Short Interest?8.9M
Days to Cover?6.1
Free Float61.4M
Avg Daily Volume1.5M
Settlement Date2026-09-15
Financial Health
Current Ratio?12.56Strong
Quick Ratio?12.56Strong
Cash Ratio?10.53Strong
Debt/Equity?0.23Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?2.18CHEAP▾
Peers100
S&P70
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-2.1CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-61.2%WEAK▾
S&P3
ROA?-45.7%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-225181000
Enterprise Value?$553.5M
Fundamentals ratios updated end of day